loadpatents
Patent applications and USPTO patent grants for Cooper; Matthew Allister.The latest application filed is for "inhibitors of sox18 protein activity for treating angiogenesis-and/or lymphangiogenesis-related diseases".
Patent | Date |
---|---|
Inhibitors of SOX18 protein activity for treating angiogenesis-and/or lymphangiogenesis-related diseases Grant 11,434,190 - Francois , et al. September 6, 2 | 2022-09-06 |
Inhibitors Of Sox18 Protein Activity For Treating Angiogenesis-and/or Lymphangiogenesis-related Diseases App 20190337880 - FRANCOIS; Mathias ;   et al. | 2019-11-07 |
Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements Grant 7,078,380 - Cooper , et al. July 18, 2 | 2006-07-18 |
Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements App 20040106544 - Cooper, Matthew Allister ;   et al. | 2004-06-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.